Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2006 Results on Thursday, February 22, 2007

Monitor this Company

MONTVALE, N.J., Feb. 15 /-/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced today that it will report its fourth quarter and full year 2006 financial results on Thursday, February 22, 2007, before the U.S. financial markets open. Management will provide a Company update and discuss the fourth quarter and full year 2006 results during a conference call on Thursday, February 22, 2007, at 9:00 a.m. EST.

    Investors and other interested parties may access the call as follows:

    Date: Thursday, February 22, 2007

    Time: 9:00 a.m. EST

    Telephone (U.S.): 866.356.4281

    Telephone (international): 617.597.5395

    Participant Passcode: 11640389

    Webcast: http://www.memorypharma.com under the

     "Investors" section

    An audio replay of the conference call will be available from 11:00 a.m. EST on Thursday, February 22, 2007, until Thursday, March 1, 2007. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 50028326. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.

    About the Company

    Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Monitor this Company :
You will receive an email alert whenever there is a news item concerning this company.
Name Your Company
Email Address Position/Role


2001 - 2016 Lexdon Business Library
About TrustBase
Privacy Policy